Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001021408-03-005438
Filing Date
2003-03-31
Accepted
2003-03-31 16:09:07
Documents
9
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 12/31/2002 d10k.txt 10-K 184929
3 LICENSE AND SUPPLY AGREEMENT dex1037.txt EX-10.37 161829
4 DEVELOPMENT AND LICENSE AGREEMENT dex1038.txt EX-10.38 214187
5 AMEND NO 1 TO COMMON STOCK PURCHASE AGEEMENT dex1039.txt EX-10.39 4141
6 INVESTMENT AND ROYALTY AGREEMENT dex1040.txt EX-10.40 96684
7 SALES FORCE WORK ORDER dex1041.txt EX-10.41 42015
8 SUBSIDIARIES dex21.txt EX-21 220
9 CEO CERTIFICATE dex991.txt EX-99.1 1368
10 CFO CERTIFICATE dex992.txt EX-99.2 1361
  Complete submission text file 0001021408-03-005438.txt   709234
Mailing Address 100 NORTH VILLAGE AVENUE STE 32 ROCKVILLE CENTRE FL 11570
Business Address 100 NORTH VILLAGE AVENUE STE 32 ROCKVILLE CENTRE NY 11570 3059336089
COLUMBIA LABORATORIES INC (Filer) CIK: 0000821995 (see all company filings)

EIN.: 592758596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-10352 | Film No.: 03630856
SIC: 2834 Pharmaceutical Preparations